MedPath

Identification of aberrant promoter methylation in liver cancer

Not Applicable
Conditions
Hepatocellular carcinoma
Registration Number
JPRN-UMIN000001317
Lead Sponsor
Graduate School of Medicine, University of Tokyo
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Sex
All
Target Recruitment
300
Inclusion Criteria

Not provided

Exclusion Criteria

None

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Incidence of aberrant DNA methylation in peripheral blood and cancer tissues of liver cancer patients
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath